183 related articles for article (PubMed ID: 21237236)
81. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
[TBL] [Abstract][Full Text] [Related]
82. Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
Rebouissou S; Franconi A; Calderaro J; Letouzé E; Imbeaud S; Pilati C; Nault JC; Couchy G; Laurent A; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
Hepatology; 2016 Dec; 64(6):2047-2061. PubMed ID: 27177928
[TBL] [Abstract][Full Text] [Related]
83. Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth.
Loesch R; Caruso S; Paradis V; Godard C; Gougelet A; Renault G; Picard S; Tanaka I; Renoux-Martin Y; Perret C; Taketo MM; Zucman-Rossi J; Colnot S
J Hepatol; 2022 Aug; 77(2):424-435. PubMed ID: 35257829
[TBL] [Abstract][Full Text] [Related]
84. Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.
Wu JF; Chang HH; Lu MY; Jou ST; Chang KC; Ni YH; Chang MH
J Biomed Sci; 2017 Aug; 24(1):62. PubMed ID: 28851352
[TBL] [Abstract][Full Text] [Related]
85. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
[TBL] [Abstract][Full Text] [Related]
86. Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?
Turato C; Buendia MA; Fabre M; Redon MJ; Branchereau S; Quarta S; Ruvoletto M; Perilongo G; Grotzer MA; Gatta A; Pontisso P
Eur J Cancer; 2012 May; 48(8):1219-26. PubMed ID: 21737255
[TBL] [Abstract][Full Text] [Related]
87. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation.
Berry RS; Gullapalli RR; Wu J; Morris K; Hanson JA
Virchows Arch; 2014 Aug; 465(2):241-5. PubMed ID: 24997695
[TBL] [Abstract][Full Text] [Related]
88. β-catenin Mutations Are Not Involved in Early-stage Hepatocarcinogenesis Induced by Protoporphyrinogen Oxidase Inhibitors in Mice.
Kuwata K; Inoue K; Ichimura R; Takahashi M; Kodama Y; Shibutani M; Yoshida M
Toxicol Pathol; 2017 Jun; 45(4):493-505. PubMed ID: 28580885
[TBL] [Abstract][Full Text] [Related]
89. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis.
Yan Z; Grenert JP; Joseph NM; Ren C; Chen X; Shafizadeh N; Kakar S
Histopathology; 2018 Jul; 73(1):101-108. PubMed ID: 29512829
[TBL] [Abstract][Full Text] [Related]
90. Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant
Comerford SA; Hinnant EA; Chen Y; Bansal H; Klapproth S; Rakheja D; Finegold MJ; Lopez-Terrada D; O'Donnell KA; Tomlinson GE; Hammer RE
JCI Insight; 2016 Oct; 1(16):e88549. PubMed ID: 27734029
[TBL] [Abstract][Full Text] [Related]
91. Immunohistochemical expression of beta-catenin in hepatoblastoma and its clinical significance.
Archana B; D'Cruze L; Nazneen S; Thanka J; Scott JX
J Cancer Res Ther; 2022; 18(3):677-680. PubMed ID: 35900540
[TBL] [Abstract][Full Text] [Related]
92. Hepatoblastoma--an attempt of histological subtyping on fine-needle aspiration material.
Barwad A; Gupta N; Gupta K; Rajwanshi A; Marwaha RK; Rao KL; Dey P; Srinivasan R; Nijhawan R
Diagn Cytopathol; 2013 Feb; 41(2):95-101. PubMed ID: 22362636
[TBL] [Abstract][Full Text] [Related]
93. Mutant
Crippa S; Ancey PB; Vazquez J; Angelino P; Rougemont AL; Guettier C; Zoete V; Delorenzi M; Michielin O; Meylan E
EMBO Mol Med; 2017 Nov; 9(11):1589-1604. PubMed ID: 28923827
[TBL] [Abstract][Full Text] [Related]
94. Microcystic stromal tumour of the ovary: frequent mutations of β-catenin (CTNNB1) in six cases.
Bi R; Bai QM; Yang F; Wu LJ; Cheng YF; Shen XX; Cai X; Zhou XY; Yang WT
Histopathology; 2015 Dec; 67(6):872-9. PubMed ID: 25913412
[TBL] [Abstract][Full Text] [Related]
95. High frequency of beta-catenin mutations in hepatoblastoma.
Udatsu Y; Kusafuka T; Kuroda S; Miao J; Okada A
Pediatr Surg Int; 2001 Sep; 17(7):508-12. PubMed ID: 11666046
[TBL] [Abstract][Full Text] [Related]
96. Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1.
Gest C; Sena S; Dif L; Neaud V; Loesch R; Dugot-Senant N; Paysan L; Piquet L; Robbe T; Allain N; Dembele D; Guettier C; Bioulac-Sage P; Rullier A; Le Bail B; Grosset CF; Saltel F; Lagrée V; Colnot S; Moreau V
JHEP Rep; 2023 May; 5(5):100691. PubMed ID: 37153687
[TBL] [Abstract][Full Text] [Related]
97. Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer.
Elmetwalli A; Nageh A; Youssef AI; Youssef M; Ahmed MAE; Noreldin AE; El-Sewedy T
Med Oncol; 2023 Dec; 41(1):38. PubMed ID: 38157146
[TBL] [Abstract][Full Text] [Related]
98. Position Is Destiny: Metabolism and Cell Identity.
Goessling W
Cell Metab; 2019 May; 29(5):1017-1019. PubMed ID: 31067445
[TBL] [Abstract][Full Text] [Related]
99. Spatial characterisation of β-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim.
Di Tommaso S; Dourthe C; Dupuy JW; Dugot-Senant N; Cappellen D; Cazier H; Paradis V; Blanc JF; Le Bail B; Balabaud C; Bioulac-Sage P; Saltel F; Raymond AA
JHEP Rep; 2024 Feb; 6(2):100913. PubMed ID: 38304236
[TBL] [Abstract][Full Text] [Related]
100. Phenotype of single hepatocytes expressing an activated version of β-catenin in liver of transgenic mice.
Schreiber S; Rignall B; Braeuning A; Marx-Stoelting P; Ott T; Buchmann A; Hammad S; Hengstler JG; Schwarz M; Köhle C
J Mol Histol; 2011 Oct; 42(5):393-400. PubMed ID: 21822615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
